NCT00608738
- Conditions
- Agranulocytosis, Blood Platelet Disorders, Chemotherapeutic Agent Toxicity, +17 more
- Locations
-
Not specified
Clinical trial condition
Infections
Explore clinical trials studying Infections. Study availability and eligibility vary by location and protocol.
1,541 public trials
227 recruiting studies
Infections trial results
NCT00003031
- Conditions
- Infection, Infections, Pulmonary Complications
- Locations
-
- Hartford Medical Group Wethersfield, Connecticut, United States
- St. Vincent's Hospital Sydney, New South Wales, Australia
- Royal Brisbane Hospital Brisbane, Queensland, Australia
- Alfred Hospital Melbourne, Victoria, Australia
NCT01060410
- Conditions
- Adverse Effects, Autoimmune Diseases, Connective Tissue Diseases, +8 more
- Locations
-
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University Guangzhou, Guangdong, China
NCT01620294
- Conditions
- Infection, Infections, Pathologic Processes, +4 more
- Locations
-
- Department of Surgery Medical Faculty, University of Pecs, Hungary Pécs, Hungary
Completed
H-IVIG Treatment for Severe H1N1 2009
NCT01617317
- Conditions
- Infections, Novel 2009 Influenza A (H1N1) Infection
- Locations
-
- The University of Hong Kong, Queen Mary Hospital Hong Kong
NCT01214993
- Conditions
- Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +20 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
NCT00450580
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Antwerp, Belgium
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Besançon, France
NCT00386347
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
- Locations
-
- GSK Investigational Site Evansville, Indiana, United States
NCT00999622
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +16 more
- Locations
-
Not specified
NCT01315457
- Conditions
- Infections, Patients Treated With Alemtuzumab
- Locations
-
- Queen Mary Hospital Hong Kong, China
- Cipto Mangunkusumo General Hospital Jakarta, Indonesia
- Samsung Medical Center Seoul, South Korea
- National Taiwan University Hospital Teipei, Taiwan